According to the Zhitong Finance App, Chia Tai Biotech (03839.HK) announced results for the first three quarters of 2026. The group achieved revenue of US$332 million, a year-on-year decrease of 22.98%; profit attributable to shareholders was US$12.147 million, a decrease of 48.39% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.